Safety and efficacy of tocilizumab in the treatment of severe acute respiratory syndrome coronavirus-2 pneumonia: A retrospective cohort study

Conclusions: TCZ is likely a safe and effective modality of treatment for improving clinical and laboratory parameters of SARS CoV-2 patients with a reduction in ICU stay and ventilatory care need.

Source: Indian Journal of Medical Microbiology - July 24, 2020 Category: Microbiology Authors: Atul Patel Kinjal Shah Mitkumar Dharsandiya Ketan Patel Tushar Patel Mukesh Patel Tea Reljic Ambuj Kumar Source Type: research